SEC Filings for Navidea Biopharmaceuticals Inc. (NAVB)

$ 1.08   0.04 (+3.85%) Volume: 50.02k 9:55 AM EST Feb 20, 2020
Filing Type:
Form TypeForm DescriptionPagesDateView
4Statement of changes in beneficial ownership of securities102/19/2020
424B5Prospectus [Rule 424(b)(5)]102/18/2020
8-KCurrent report pursuant to Section 13 or 15(d)202/18/2020
8-KCurrent report pursuant to Section 13 or 15(d)302/14/2020
4Statement of changes in beneficial ownership of securities102/07/2020
4Statement of changes in beneficial ownership of securities102/07/2020
4Statement of changes in beneficial ownership of securities102/07/2020
4Statement of changes in beneficial ownership of securities102/07/2020
4Statement of changes in beneficial ownership of securities102/07/2020
4Statement of changes in beneficial ownership of securities102/07/2020
S-3Registration statement under Securities Act of 1933412/31/2019
8-KCurrent report pursuant to Section 13 or 15(d)212/30/2019
<<
First
<
Prev
123456789101112131415